1. Home
  2. PTCT vs RELY Comparison

PTCT vs RELY Comparison

Compare PTCT & RELY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • RELY
  • Stock Information
  • Founded
  • PTCT 1998
  • RELY 2011
  • Country
  • PTCT United States
  • RELY United States
  • Employees
  • PTCT N/A
  • RELY N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • RELY Computer Software: Prepackaged Software
  • Sector
  • PTCT Health Care
  • RELY Technology
  • Exchange
  • PTCT Nasdaq
  • RELY Nasdaq
  • Market Cap
  • PTCT 3.9B
  • RELY 4.6B
  • IPO Year
  • PTCT 2013
  • RELY 2021
  • Fundamental
  • Price
  • PTCT $48.55
  • RELY $17.64
  • Analyst Decision
  • PTCT Buy
  • RELY Buy
  • Analyst Count
  • PTCT 14
  • RELY 10
  • Target Price
  • PTCT $63.57
  • RELY $27.40
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • RELY 3.6M
  • Earning Date
  • PTCT 08-07-2025
  • RELY 07-30-2025
  • Dividend Yield
  • PTCT N/A
  • RELY N/A
  • EPS Growth
  • PTCT N/A
  • RELY N/A
  • EPS
  • PTCT 7.51
  • RELY N/A
  • Revenue
  • PTCT $1,772,758,000.00
  • RELY $1,356,469,000.00
  • Revenue This Year
  • PTCT $121.50
  • RELY $27.85
  • Revenue Next Year
  • PTCT N/A
  • RELY $20.30
  • P/E Ratio
  • PTCT $6.45
  • RELY N/A
  • Revenue Growth
  • PTCT 91.12
  • RELY 34.37
  • 52 Week Low
  • PTCT $29.02
  • RELY $12.43
  • 52 Week High
  • PTCT $58.38
  • RELY $27.32
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 46.94
  • RELY 30.46
  • Support Level
  • PTCT $47.52
  • RELY $18.04
  • Resistance Level
  • PTCT $49.73
  • RELY $18.83
  • Average True Range (ATR)
  • PTCT 1.46
  • RELY 0.64
  • MACD
  • PTCT -0.19
  • RELY -0.07
  • Stochastic Oscillator
  • PTCT 36.28
  • RELY 1.16

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About RELY Remitly Global Inc.

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

Share on Social Networks: